Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101930404 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IMPAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FZD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA2D2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TYMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC440862 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDLRAD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R12A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
G2E3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ULK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC30A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on